2 unchanged sentences
Exhibit Description
−Removed: Form of Promissory Note (YA II PN, Ltd.)
−Removed: Form of Warrant (YA II PN, Ltd.)
−Removed: Securities Purchase Agreement by and between PDS Biotechnology
−Removed: Corporation and YA II PN, Ltd., dated as of April 30, 2026
−Removed: Form of Registration Rights Agreement (YA II PN, Ltd.)
−Removed: Form of Guaranty Agreement (YA II PN, Ltd.)
−Removed: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
−Removed: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
+Added: Sales Agreement, dated June 15, 2026, by and among PDS Biotechnology Corporation, Yorkville Securities, LLC and B.
+Added: Riley Securities, Inc.
+Added: Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on June 15, 2026, and incorporated by reference herein
+Added: Form of Promissory Note (YA II PN, Ltd.) (filed as Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2026, and incorporated
+Added: by reference herein)
+Added: Form of Warrant (YA II PN, Ltd.) filed as Exhibit 4.2 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2026, and incorporated by
+Added: reference herein)
+Added: Securities Purchase Agreement by and between PDS Biotechnology Corporation and YA II PN, Ltd., dated as of April 30, 2026 (filed as Exhibit 10.1 to
+Added: the Company’s Current Report on Form 8- K filed on June 15, 2026, and incorporated by reference herein)
+Added: Form of Registration Rights Agreement (YA II PN, Ltd.) (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2026,
+Added: and incorporated by reference herein)
+Added: Form of Guaranty Agreement (YA II PN, Ltd.) (filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed on May 14, 2026, and
+Added: incorporated by reference herein)
+Added: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant
+Added: to Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant
+Added: to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of Principal Executive Officer Pursuant to 18 U.S.C.
−Removed: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
+Added: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
+Added: (furnished herewith).
Certification of Principal Financial Officer Pursuant to 18 U.S.C.
−Removed: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
−Removed: Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
+Added: Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
+Added: (furnished herewith).
+Added: Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the
+Added: Inline XBRL document.
Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents.
5 unchanged sentences
Filed herewith (unless otherwise noted as being furnished herewith)
−Removed: Pursuant to Item 601(a)(5) of Regulation S-K, schedules have been omitted and will be furnished on a supplemental basis to the Securities and Exchange Commission upon request.
−Removed: Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: Pursuant to Item 601(a)(5) of Regulation S-K, schedules have been omitted and will be furnished on a supplemental basis to the Securities and Exchange Commission upon
+Added: Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly
PDS Biotechnology Corporation
+Added: August 13, 2026
/s/ Frank Bedu-Addo
2 unchanged sentences
(Principal Executive Officer)
+Added: August 13, 2026
/s/ Lars Boesgaard
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.